World Health Organization along with 37 countries appealed for common possession of vaccines, medicines, and diagnostic tools to prevent the global pandemic. The idea comes as many countries fear that patent rights would barrage them from accessing necessary supplies, Reuters reported.
The appeal was made mostly by developing nations under the Covid-19 Technology Access Pool. The proposal was praised by Doctors Without Borders.
Developing nations are apprehensive of rich countries trying to lay claims over upcoming vaccines and medicines as they are pumping resources in the development of more than 100 vaccines.
"Vaccines, tests, diagnostics, treatments, and other key tools in the coronavirus response must be made universally available as global public goods," said Costa Rica President Carlos Alvarado.
The effort, originally proposed in March, aims to provide a one-stop-shop for scientific knowledge, data, and intellectual property to tackle the pandemic that has infected more than 5.8 million people and killed more than 360,000.
The WHO issued a "Solidarity Call to Action", asking other stakeholders to join the voluntary push.
"WHO recognizes the important role that patents play in fuelling innovation but this is a time when people must take priority," WHO Director-General Tedros Adhanom Ghebreyesus told an online news briefing.
The International Federation of Pharmaceutical Manufacturers & Associations raised concerns about undermining intellectual property protections, which the group said already enable collaboration and will also be needed after the pandemic is over.
"The 'Solidarity Call to Action' promotes a one-size-fits-all model that disregards the specific circumstances of each situation, each product, and each country," the federation said as cited in the Reuters report.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.